(Q38343378)

2 September 2017

title

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease (English)

1 reference

2 September 2017

0 references

3

Henrik Zetterberg

1 reference

2 September 2017

11

Kaj Blennow

1 reference

2 September 2017

Boris Lenhard

8

0 references

Boo Johansson

5

object named as

Boo Johansson

1 reference

2 September 2017

9

Anthony J Brookes

1 reference

2 September 2017

10

Nancy L Pedersen

1 reference

2 September 2017

4

Lars Feuk

1 reference

2 September 2017

Annica Johansson

1

1 reference

2 September 2017

Hagit Katzov

2

1 reference

2 September 2017

Nenad Bogdanovic

6

1 reference

2 September 2017

Niels Andreasen

7

1 reference

2 September 2017

Jonathan A Prince

12

1 reference

2 September 2017

language of work or name

1 reference

18 March 2004

1 reference

2 September 2017

1 reference

2 September 2017

volume

114

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

581-587

1 reference

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

2 September 2017

cites work

1 reference

12 December 2020

DNA binding sites: representation and discovery

1 reference

12 December 2020

JASPAR: an open-access database for eukaryotic transcription factor binding profiles

1 reference

12 December 2020

Cholesterol, A beta and Alzheimer's disease

1 reference

12 December 2020

Amyloid metabolism and secretases in Alzheimer's disease

1 reference

12 December 2020

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

1 reference

12 December 2020

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

1 reference

12 December 2020

The UCSC Genome Browser Database

1 reference

12 December 2020

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

12 December 2020

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

12 December 2020

Alzheimer's disease: the cholesterol connection

1 reference

12 December 2020

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

1 reference

12 December 2020

Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

1 reference

12 December 2020

Identification of conserved regulatory elements by comparative genome analysis

1 reference

12 December 2020

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.

1 reference

12 December 2020

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

12 December 2020

The HUGO Gene Nomenclature Committee (HGNC).

1 reference

12 December 2020

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro.

1 reference

12 December 2020

Cholesterol and Alzheimer's disease: is there a link?

1 reference

12 December 2020

Estimation of linkage disequilibrium in randomly mating populations

1 reference

12 December 2020

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

12 December 2020

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

12 December 2020

Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

1 reference

12 December 2020

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

12 December 2020

Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Genetic variation in a haplotype block spanningIDE influences Alzheimer disease

1 reference

12 December 2020

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

1 reference

12 December 2020

Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation

1 reference

12 December 2020

10.1007/S00439-004-1107-9

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1020506882

0 references

1 reference